Aquestive Therapeutics, Inc.
Aquestive Therapeutics, Inc. (AQST) is a publicly traded company in the Unknown sector. Across all available filings, 18 corporate insiders have executed 177 transactions totaling $6.7M, demonstrating a bearish sentiment with -$458.4K in net insider flow. The most recent transaction on Dec 4, 2025 involved a transaction of 20,000 shares valued at $0.
AQST Insider Activity Summary
Who Is Buying AQST Stock?
No significant insider buying has been recorded for AQST in the recent period.
Who Is Selling AQST Stock?
No significant insider selling has been recorded for AQST in the recent period.
Is Aquestive Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for AQST is bearish with an Insider Alignment Score of 47/100 and a net flow of -$458.4K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
AQST Frequently Asked Questions
Understanding AQST Insider Activity
Insider trading at Aquestive Therapeutics, Inc. (AQST) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 18 insiders are actively trading AQST stock, having executed 177 transactions in the past 90 days. The most active insider is Capital Management, L.p. Bratton (Executive), who has made 8 transactions totaling $2.5M.
Related Tools
Track Aquestive Therapeutics, Inc. Insider Activity
Get notified when executives and directors at AQST file new Form 4 transactions